Dexcom’s investigational 15-day continuous glucose monitor has a lower mean absolute relative difference than the current ...

The agency cited quality issues at facilities testing Dexcom’s G6 and G7 monitors, including inadequate validation and risk ...

Dexcom made a significant design change to a component used in its sensors and did not adequately validate the change, ...

In a new study in the peer-reviewed journal Diabetes Technology & Therapeutics (DTT), investigators evaluated the accuracy of the 15.5-day Dexcom G7 integrated continuous glucose monitor (CGM) in ...

The Dexcom G7 CGM System is designed to be user-friendly ... transmits your blood glucose readings in real time to a handheld receiver or smart device. Patients can control their glucose and ...

DexCom receives a warning letter from the FDA citing several issues with its popular G6 & G7 sensor manufacturing. The company response is inadequate. DexCom (NasdaqGS:DXCM) witnessed a 4% ...

Jake Leach caught up with MedTech Dive during the ATTD conference to discuss new data on the company’s glucose monitors and ...

At the conference, first-ever accuracy and performance data will be presented for Dexcom’s upcoming G7 15 Day system, 1 showing an overall mean absolute relative difference (MARD) of 8.0% ...

Nanowear announced that it entered into a partnership with Dexcom to ingest glucose data from its latest continuous glucose ...

Users should always confirm readings and trend on the Dexcom G7 app or receiver before making treatment decisions. * Separate Dexcom Follow app and internet connection required. Source ...